The U.S. District Court for the District of New Jersey has ruled, in Ferring Pharmaceuticals Inc. v. Watson Pharmaceuticals, Inc., et al., that the pharmaceutical company Actavis Pharma has standing to bring its claims alleging that Ferring violated the Computer Fraud and Abuse Act (CFAA) and the New Jersey computer crime statute by improperly accessing a password-protected webcast about its in vitro fertilization (IVF) product.  The court found that Actavis’ allegations that Ferring evaded the password protections in order to access the site was sufficient to state a claim of unauthorized access to a protected computer.  It also held that the cost of responding to the breach satisfied the requirement of showing loss.  The latter point is an issue that has split the courts, and this court’s broad interpretation of “loss” is helpful for companies that suffer data breaches.